Applikationen
Applikationssuche / -filter
| Klassifizierung | Dokumentenname | Verbindung | Produktcode | Säule | |
| Pharmaceuticals, Drugs, Metabolites | Xanthine oxidase inhibitor and its metabolites - method transfer to ultra-fast LC | Uric acid Hypoxanthine Xanthine Oxipurinol Allopurinol | HS12S02-0502WT | Hydrosphere C18 | |
| Pharmaceuticals, Drugs, Metabolites | Simvastatin tablets (JP draft) | Simvastatin | TA12S05-2546WT | YMC-Triart C18 | |
| Pharmaceuticals, Drugs, Metabolites | Adrenocorticosteroids | Fluocinolone acetonide Prednisolone acetate Deoxycorticosterone Fluocinonide | JM08S04-1546WT | J'sphere ODS-M80 | |
| Pharmaceuticals, Drugs, Metabolites | Simvastatin (JP 16th| Assay) | Simvastatin Lovastatin | TA12S03-H546WT | YMC-Triart C18 | |
| Pharmaceuticals, Drugs, Metabolites | Adrenocorticosteroids | Fluocinolone acetonide Prednisolone acetate Deoxycorticosterone Fluocinonide | AA12S05-1546WT | YMC-Pack ODS-A | |
| Pharmaceuticals, Drugs, Metabolites | Simvastatin (USP 34th| Assay) | Simvastatin Lovastatin | TA12S03-H546WT | YMC-Triart C18 | |
| Pharmaceuticals, Drugs, Metabolites | Luliconazole | Luliconazole | KSA99S05-2546WT | CHIRAL ART Amylose-SA | |
| Pharmaceuticals, Drugs, Metabolites | Olopatadine hydrochloride ophthalmic solution (USP 34th|Assay) | Olopatadine hydrochloride | TO12S05-1546WT | YMC-Triart C8 | |
| Pharmaceuticals, Drugs, Metabolites | Oxybutynin | Oxybutynin | KSA99S05-2546WT | CHIRAL ART Amylose-SA | |
| Pharmaceuticals, Drugs, Metabolites | Olopatadine hydrochloride (JP draft|Related substances) | Olopatadine hydrochloride | TO12S05-2546WT | YMC-Triart C8 | |
| Pharmaceuticals, Drugs, Metabolites | Propiomazine | Propiomazine | KBN99S05-2546WT | CHIRAL ART Amylose-C (Neo) | |
| Pharmaceuticals, Drugs, Metabolites | Olopatadine hydrochloride tablets (JP draft|Assay, Dissolution) | Olopatadine hydrochloride Doxepine hydrochloride (I.S.) | TO12S05-2546WT | YMC-Triart C8 | |
| Pharmaceuticals, Drugs, Metabolites | Sterols | Brassicasterol Cholesterol Fucosterol Stigmasterol Campesterol β-Sitosterol | AL12S05-2546WT | YMC-Pack ODS-AL | |
| Pharmaceuticals, Drugs, Metabolites | Tadalafil | Tadalafil | KBN99S05-2546WT | CHIRAL ART Amylose-C (Neo) | |
| Pharmaceuticals, Drugs, Metabolites | Sterols | Brassicasterol Cholesterol Fucosterol Stigmasterol Campesterol β-Sitosterol | JM08S04-2546WT | J'sphere ODS-M80 | |
| Pharmaceuticals, Drugs, Metabolites | Ibrutinib | Ibrutinib | KCN99S05-2546WT | CHIRAL ART Cellulose-C | |
| Pharmaceuticals, Drugs, Metabolites | Sterols | Brassicasterol Cholesterol Fucosterol Stigmasterol Campesterol β-Sitosterol | AL12S05-2546WT | YMC-Pack ODS-AL | |
| Pharmaceuticals, Drugs, Metabolites | Galantamine | Galantamine | KBN99S05-2546WT | CHIRAL ART Amylose-C (Neo) | |
| Pharmaceuticals, Drugs, Metabolites | The right HIC column for each separation: BioPro HIC HT and BioPro HIC BF | Adalimumab (Humira®) Trastuzumab (Herceptin®) | BHB00S04-1046WT | BioPro HIC BF | |
| Pharmaceuticals, Drugs, Metabolites | LC/MS analysis of tetracycline antibiotics | Oxytetracycline Tetracycline Chlortetracycline Doxycycline | TA12S05-0502WT | YMC-Triart C18 |
